A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 979
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : HAND
Long Form : HIV-associated neurocognitive disorders
No. Year Title Co-occurring Abbreviation
2021 A comprehensive data-driven analysis framework for detecting impairments in brain function networks with resting state fMRI in HIV-infected individuals on cART. cART, CNS, rs-fMRI
2021 A Rat Model of EcoHIV Brain Infection. ---
2021 Activation of α7 nicotinic acetylcholine receptor ameliorates HIV-associated neurology and neuropathology. alpha7nAChR, iTat
2021 Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS. AIDS, CNS, NHPs, SHIV, SIV, SIVE
2021 Advances in the Experimental Models of HIV-Associated Neurological Disorders. CNS
2021 Altered expression of fractalkine in HIV-1-infected astrocytes and consequences for the virus-related neurotoxicity. CNS
2021 Association between personality and cognitive performance in middle-aged and older adults with human immunodeficiency virus (HIV). HIV
2021 Astrocyte HIV-1 Tat Differentially Modulates Behavior and Brain MMP/TIMP Balance During Short and Prolonged Induction in Transgenic Mice. ART, Dox, iTat, MMPs, PLWH, Tat, TIMPs
2021 Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. BBBi, cART, CNS, CSAR, CSF, PLWH
10  2021 Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress. ARTs, HIV
11  2021 Can Individualized-Targeted Computerized Cognitive Training Benefit Adults with HIV-Associated Neurocognitive Disorder? The Training on Purpose Study (TOPS). PWH, SOP, SOP, TOPS
12  2021 Can individualized-targeted computerized cognitive training improve everyday functioning in adults with HIV-associated neurocognitive disorder? HIV, TOPS
13  2021 Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review. ART, CSF, PLWH
14  2021 Connectome-based prediction of global cognitive performance in people with HIV. CPM, PWH
15  2021 Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status. FIs, NNRTIs, NRTIs
16  2021 Deep Phenotyping of HIV Neurocognitive Complications Among Individuals Residing in High-Income Countries. ART, HICs, PLWH
17  2021 Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism. CNS, rods
18  2021 Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice. BDNF, cART, MWM
19  2021 Ensemble machine learning classification of daily living abilities among older people with HIV. ADLs, AUC, FA, GBM, NAB-DLM, PWH, RD, UCSF, WRAT-4
20  2021 Extracellular Microvesicles Released From Brain Endothelial Cells are Detected in Animal Models Of HIV-1 Signifying Unresolved Inflammation. ART, EC, EVs, TJP
21  2021 Extracellular vesicles regulate gap junction-mediated intercellular communication and HIV-1 infection of human neural progenitor cells. CNS, Cx43, EV-Abeta, EVs, GJ, HBMEC, HIV-1, hNPCs, p-Cx43, Panx2
22  2021 GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration. AEA, FAAH, HIV-1, MCM
23  2021 Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV. AUC, GMV
24  2021 Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIV. CSF, GDS, PWH
25  2021 HIV Associated Neurocognitive Disorders Subsidence Through Citalopram Addition in Anti-retroviral Therapy (HANDS-CARE): A Concept Note. HAART, SSA
26  2021 HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure. CNS
27  2021 HIV Neuroinflammation: The Role of Exosomes in Cell Signaling, Prognostic and Diagnostic Biomarkers and Drug Delivery. BBB, CNS
28  2021 HIV TAT-mediated microglial senescence: Role of SIRT3-dependent mitochondrial oxidative stress. cART, mPMs
29  2021 HIV transgenic rats demonstrate impaired sensorimotor gating, but are insensitive to cannabinoid (Δ9-tetrahydrocannabinol)-induced deficits. CBD, HIVtg, PPI, PWH, THC, WT
30  2021 HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV. ---
31  2021 HIV-1 gp120-Induced Endolysosome de-Acidification Leads to Efflux of Endolysosome Iron, and Increases in Mitochondrial Iron and Reactive Oxygen Species. DMT1, PLWH, ROS
32  2021 HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins. ANI, CNS
33  2021 HIV-induced neuroinflammation inhibits oligodendrocyte maturation via glutamate-dependent activation of the PERK arm of the integrated stress response. AMPAR, cART, ISR, KA, OL, OPCs
34  2021 IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments. OCB, PWH
35  2021 Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application. CBTs, HIV, IBD, MS, RCTs, SNPs
36  2021 Impact of MBL-2 coding region polymorphism on modulation of HAND and HIV-1 acquisition. MBL2
37  2021 In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain. mPFC, Tat, Tat-tg
38  2021 Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders. cART, CNS, CPE
39  2021 Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women. CT, CTQ, RTL
40  2021 Magnetic Nanoparticle and Exosomal Therapeutic (M-NEXT) Effects on HIV-Associated Neurotoxicity. BBB, gp120, HIV, M-NEXT, M-NEXT, MNPs, TEER, xEVs
41  2021 Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders. ---
42  2021 Methamphetamine and HIV-Tat Protein Synergistically Induce Oxidative Stress and Blood-Brain Barrier Damage via Transient Receptor Potential Melastatin 2 Channel. 8-Br-ADPR, BBB, CAT, EB, GSH-Px, JAMA, MDA, METH, NACA, ROS, SOD, TJ, TRPM2, ZO-1
43  2021 Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders? cART, CNS, HIV-1
44  2021 Mini review: Promotion of substance abuse in HIV patients: Biological mediation by HIV-1 Tat protein. SUD
45  2021 Mini-review: The therapeutic role of cannabinoids in neuroHIV. cART, eCB, HIV-1
46  2021 Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat. 2-AG, AA, AEA, HIV-1, MAGL, PFC, Tat
47  2021 Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way Forward. ANI, PWH
48  2021 Penetrating the Blood-Brain Barrier with New Peptide-Porphyrin Conjugates Having anti-HIV Activity. BBB, PDCs, PPCs
49  2021 Predicting occupational outcomes from neuropsychological test performance in older people with HIV. ---
50  2021 Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania. cART, HANDs, PLWH
51  2021 Proteomics and metabolomics of HIV-associated neurocognitive disorders: A systematic review. CNS, CSF, HIV, PLWH
52  2021 Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment. ANI, AUC, CN, IHDS, MoCA, ROC
53  2021 Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study. PLWH, QoL
54  2021 Reductions in Gray Matter Linked to Epigenetic HIV-Associated Accelerated Aging. ---
55  2021 Rho-kinase inhibitor hydroxyfasudil protects against HIV-1 Tat-induced dysfunction of tight junction and neprilysin/Aβ transfer receptor expression in mouse brain microvessels. BBB, EB, HF, LRP1, NEP, qRT-PCR, RAGE, Tat, TJ, ZO-1
56  2021 S-Equol mitigates motivational deficits and dysregulation associated with HIV-1. SE, Tg
57  2021 Synergistic Effect and Mechanism of Apoptosis Induction by Morphine and the HIV-1gp120V3 Loop in Hippocampal Neurons. ERK
58  2021 TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use. METH, TCA
59  2021 Telomere Length Shortening in Microglia: Implication for Accelerated Senescence and Neurocognitive Deficits in HIV. cART, CNS, PBMC, RP, TL
60  2021 The clinical and demographic profile of women living with HIV admitted to the acute unit at Stikland Psychiatric Hospital. ART, HIV, IHDS, MoCA
61  2021 The HIV-1 matrix protein p17 does cross the Blood-Brain Barrier. BBB, CNS, HIV-1
62  2021 Treating viruses in the brain: Perspectives from NeuroAIDS. CNS, CSF
63  2021 Triumeq Increases Excitability of Pyramidal Neurons in the Medial Prefrontal Cortex by Facilitating Voltage-Gated Ca2+ Channel Function. 4wks, ABC, ARVs, cART, DTG, HVA, LVA, mPFC, PLWH
64  2021 Uptake of Biotinylated Spermine in Astrocytes: Effect of Cx43 siRNA, HIV-Tat Protein and Polyamine Transport Inhibitor on Polyamine Uptake. b-SPM, CSF, Cx43-HCs, PAs, PTI
65  2021 Utility of a Short Neuropsychological Protocol for Detecting HIV-Associated Neurocognitive Disorders in Patients with Asymptomatic HIV-1 Infection. HIV-1, IHDS, MMSE
66  2021 [Neuropsychiatric comorbidity in HIV infection]. MDD
67  2021 [SBi4211 alleviates gp120-induced central nervous system injury via inhibiting S100B/ RAGE]. CCK-8, Tg
68  2020 A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders. SYP
69  2020 A Novel Concept is Needed for Combating Alzheimer's Disease and NeuroHIV. AD, ADRD, HAD, NMDARs, VGCCs
70  2020 A pivotal role for Interferon-α receptor-1 in neuronal injury induced by HIV-1. cART, CNS, IFNAR, IFNAR1KO, tg
71  2020 Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies. AD, BBB, HIV
72  2020 An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia. ART, BBB, CNS, HIV-1, HIVE, NSG
73  2020 Assessing HIV provider knowledge, screening practices, and training needs for HIV-associated neurocognitive disorders. A short report. ---
74  2020 Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1-infected patients. ART, IQR, NCIs
75  2020 Astrocytes, HIV and the Glymphatic System: A Disease of Disrupted Waste Management? AD, AQP4, CSF, ISF, pTau, PWH
76  2020 Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period. ANI, NP-N
77  2020 Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. ANI, ART, HAD, MND, p-tau, PWH
78  2020 Brain amyloid in virally suppressed HIV-associated neurocognitive disorder. AD, AIBL, APOE, MCI
79  2020 Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders. PWH
80  2020 Chemokine CCL2 impairs spatial memory and cognition in rats via influencing inflammation, glutamate metabolism and apoptosis-associated genes expression- a potential mechanism for HIV-associated neurocognitive disorder. CCL2, MWM, NORT
81  2020 Combination of HIV-1 and Diabetes Enhances Blood Brain Barrier Injury via Effects on Brain Endothelium and Pericytes. ART, BBB, DM
82  2020 Cross-talk between lipid homeostasis and endoplasmic reticulum stress in neurodegeneration: Insights for HIV-1 associated neurocognitive disorders (HAND). AD, ER, HD, PD, PQC, UPR
83  2020 Cultural Neuropsychology Considerations in the Diagnosis of HIV-Associated Neurocognitive Disorders. CALD, HIV
84  2020 CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility. ---
85  2020 Detecting cognitive impairment in HIV-infected individuals using mutual connectivity analysis of resting state functional MRI. DOS, HIV, MCA, NBS
86  2020 Determining the Neurocognitive Status and the Functional Ability of Patients to Screen for HIV-Associated Neurocognitive Disorder (HAND). ART, MoCA, PLHIV
87  2020 Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infection. cART, HIV
88  2020 Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy. cART, CHARTER, CNS, CSF, DRMs, SGA
89  2020 Effect of human immunodeficiency virus on the brain: A review. HIV
90  2020 Effect of Human Immunodeficiency Virus on Trace Elements in the Brain. HIV
91  2020 Effects of HIV gp120 on Neuroinflammation in Immunodeficient vs. Immunocompetent States. ---
92  2020 Elevated Plasma Levels of sCD14 and MCP-1 Are Associated With HIV Associated Neurocognitive Disorders Among Antiretroviral-Naive Individuals in Nigeria. ANI, HAD, MCP-1, MND, sCD14, TNF-alpha
93  2020 Emerging Role of Nef in the Development of HIV Associated Neurological Disorders. EVs, Nef
94  2020 Endoplasmic reticulum stress and autophagy in HIV-1-associated neurocognitive disorders. ART, ER
95  2020 Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND. ART, CNS, HIV-1, Tat
96  2020 Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis. ART, CI
97  2020 Glycogen synthase kinase-3 inhibition rescues sex-dependent contextual fear memory deficit in human immunodeficiency virus-1 transgenic mice. GSK-3, Tg26
98  2020 HIV gp120 Protein Increases the Function of Connexin 43 Hemichannels and Pannexin-1 Channels in Astrocytes: Repercussions on Astroglial Function. Cx43, HIV
99  2020 HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History. cART
100  2020 HIV influences microtubule associated protein-2: potential marker of HIV-associated neurocognitive disorders. CSF, MAP2, PLH